Data completeness
2/8 — Basic
BETAMETHASONE VALERATE (betamethasone valerate) by Sandoz is clinical pharmacology: topical corticosteroids share anti-inflammatory, antipruritic and vasoconstrictive actions.
Drug data last refreshed 21h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Betamethasone valerate is a topical corticosteroid lotion that reduces inflammation, itching, and skin vascularity through unclear but well-characterized anti-inflammatory mechanisms. It is absorbed through intact and inflamed skin, with absorption enhanced by occlusive dressings, and is metabolized hepatically before renal and biliary excretion. Indicated for inflammatory and pruritic dermatological conditions responsive to topical corticosteroid therapy.
$0.004BPart D
Pre-LaunchEarly-stage product with minimal current market footprint; career opportunity tied to launch execution and market penetration strategy.
Mechanism of Action
CLINICAL PHARMACOLOGY: Topical corticosteroids share anti-inflammatory, antipruritic and vasoconstrictive actions. The mechanism of anti-inflammatory activity of the topical corticosteroids is unclear. Various laboratory methods, including vasoconstrictor assays, are used to compare and predict…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Worked on BETAMETHASONE VALERATE at Sandoz? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.